Samantha J. Montague

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

A systematic review of vaccine-induced immune thrombosis and thrombocytopenia triggered by non-adenoviral vector vaccination: ultra-rare or non-existent?

A systematic review of vaccine-induced immune thrombosis and thrombocytopenia triggered by non-adenoviral vector vaccination: ultra-rare or non-existent?

Journal: Haematologica

Published: December 08, 2025

Platelet triggering receptor expressed on myeloid cells-like transcript 1 regulation in healthy donors and patients at risk of bleeding and thrombosis.

Platelet triggering receptor expressed on myeloid cells-like transcript 1 regulation in healthy donors and patients at risk of bleeding and thrombosis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 05, 2025

Platelet TREM-Like Transcript-1 (TLT-1) regulation in healthy donors and patients at risk of bleeding and thrombosis.

Platelet TREM-Like Transcript-1 (TLT-1) regulation in healthy donors and patients at risk of bleeding and thrombosis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 05, 2025

Scott syndrome with novel compound heterozygous pathogenic variants in ANO6 and reduced thrombin generation.

Scott syndrome with novel compound heterozygous pathogenic variants in ANO6 and reduced thrombin generation.

Journal: Haematologica

Published: October 27, 2025

Platelet aggregation responses to Salmonella Typhimurium are determined by host anti-Salmonella antibody levels.

Platelet aggregation responses to Salmonella Typhimurium are determined by host anti-Salmonella antibody levels.

Journal: Platelets

Published: December 16, 2024

Platelet-specific SLFN14 deletion causes macrothrombocytopenia and platelet dysfunction through dysregulated megakaryocyte and platelet gene expression.

Platelet-specific SLFN14 deletion causes macrothrombocytopenia and platelet dysfunction through dysregulated megakaryocyte and platelet gene expression.

Journal: The Journal of clinical investigation

Published: December 11, 2024

Corrigendum to 'Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand': Journal of Thrombosis and Haemostasis, Volume 22, Issue 1, (January 2024) Pages 271-285.

Corrigendum to 'Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand': Journal of Thrombosis and Haemostasis, Volume 22, Issue 1, (January 2024) Pages 271-285.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 20, 2024

Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics.

Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics.

Journal: British journal of haematology

Published: May 04, 2024

Tissue inhibitors of metalloproteinases (TIMPs) modulate platelet ADAM10 activity.

Tissue inhibitors of metalloproteinases (TIMPs) modulate platelet ADAM10 activity.

Journal: Platelets

Published: November 30, 2023

Comprehensive functional characterization of a novel ANO6 variant in a new patient with Scott syndrome.

Comprehensive functional characterization of a novel ANO6 variant in a new patient with Scott syndrome.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 11, 2023

Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand.

Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand.

Journal: Journal of thrombosis and haemostasis : JTH

Published: August 07, 2023

Antagonistic Roles of Human Platelet Integrin αIIbβ3 and Chemokines in Regulating Neutrophil Activation and Fate on Arterial Thrombi Under Flow.

Antagonistic Roles of Human Platelet Integrin αIIbβ3 and Chemokines in Regulating Neutrophil Activation and Fate on Arterial Thrombi Under Flow.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: July 06, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026